A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

被引：0
|
作者：
Xin Tang
Yuan Li
Wen-lei Qian
Wei-feng Yan
Tong Pang
You-ling Gong
Zhi-gang Yang
机构：
[1] West China Hospital,Department of Radiology
[2] Sichuan University,Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center
[3] West China Hospital,undefined
[4] Sichuan University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Osimertinib; EGFR-T790M; Non-small cell lung cancer; Prognostic analysis; Real-world study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：2475 / 2486
页数：11
相关论文
共 50 条
  • [31] Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients with Both T790M and Sensitizing EGFR Mutation
    Lee, J. C.
    Yang, S.
    Oh, D. K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S806 - S807
  • [32] Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation
    Dogan, I.
    Gurbuz, M.
    Paksoy, N.
    Khanmamadov, N.
    Vatansever, S.
    Saip, P.
    Demirkazik, A.
    Aydiner, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1351 - S1351
  • [33] ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort
    Passaro, A.
    Metro, G.
    Tiseo, M.
    Migliorino, M. R.
    Santo, A.
    Sperandi, F.
    Maione, P.
    Puppo, G.
    Grossi, F.
    Parra, H. J. Soto
    Borra, G.
    Roca, E.
    Rocco, D.
    Stasi, I.
    Galetta, D.
    Carta, A. M.
    Milella, M.
    Fasola, G.
    Gebbia, V.
    Ferrari, S.
    De Marinis, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation Receiving Third-Generation EGFR-TKI Osimertinib Treatment
    Tang, Xin
    Li, Yuan
    Yan, Wei-feng
    Qian, Wen-lei
    Pang, Tong
    Gong, You-ling
    Yang, Zhi-gang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Real-world analysis of the prognostic value of EGFR mutation detection in plasma ctDNA from patients with advanced non-small cell lung cancer
    Long, Chaolian
    Li, Kun
    Liu, Zichen
    Zhang, Nana
    Xing, Xuya
    Xu, Liming
    Gai, Fei
    Che, Nanying
    CANCER MEDICINE, 2023, 12 (07): : 7982 - 7991
  • [36] Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
    Jenkins, Suzanne
    Yang, James C-H.
    Ramalingam, Suresh S.
    Yu, Karen
    Patel, Sabina
    Weston, Susie
    Hodge, Rachel
    Cantarini, Mireille
    Janne, Pasi A.
    Mitsudomi, Tetsuya
    Goss, Glenwood D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1061 - 1070
  • [37] ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer
    de Marinis, Filippo
    Wu, Yi-Long
    de Castro Jr, Gilberto
    Chang, Gee-Chen
    Chen, Yuh-Min
    Cho, Byoung Chul
    Freitas, Helano C.
    Jiang, Liyan
    Kim, Sang-We
    Martin, Claudio
    Metro, Giulio
    Provencio, Mariano
    Vansteenkiste, Johan
    Vicente, David
    Zhou, Qing
    Miranda, Miguel F.
    Bakker, Nicolaas A.
    Rigas, James R.
    Cheema, Parneet K.
    FUTURE ONCOLOGY, 2019, 15 (26) : 3003 - 3014
  • [38] Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells
    Katayama, Yuki
    Yamada, Tadaaki
    Tokuda, Shinsaku
    Okura, Naoko
    Nishioka, Naoya
    Morimoto, Kenji
    Tanimura, Keiko
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Horinaka, Mano
    Sakai, Toshiyuki
    Kita, Kenji
    Yano, Seiji
    Takayama, Koichi
    CANCER MEDICINE, 2022, 11 (04): : 944 - 955
  • [39] ASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses
    Provencio, M.
    Cheema, P. K.
    Vansteenkiste, J. F.
    Cho, B. C.
    Zhou, C.
    Yu, J.
    Martin, C.
    Park, K.
    He, Y.
    Hu, Y.
    Vicente, D.
    Miranda, M.
    Rigas, J.
    de Marinis, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells
    Wang, Rou-Hsin
    Chang, Chien-Jen
    Chen, Chien-Hung
    Liu, Kuang-Kai
    Chao, Jui-, I
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (11) : 1309 - 1319
12345